Gene · 6240
Papers3,003
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,003
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| microRNAs Associated with Gemcitabine Resistance via EMT, TME, and Drug Metabolism in Pancreatic Cancer. | Cancers (Basel) | 2023 | 36831572 | PubTator, text mining | PubMed |
| RNA-Binding Proteins in Bladder Cancer. | Cancers (Basel) | 2023 | 36831493 | PubTator, text mining | PubMed |
| The Prognostic Role of HuR Varies Between Different Subtypes of Breast Cancer Patients: Data Mining and Retrospective Analysis. | Breast Cancer (Dove Med Press) | 2023 | 36816839 | PubTator, text mining | PubMed |
| Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study. | MedComm (2020) | 2023 | 36814688 | PubTator, text mining | PubMed |
| The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia. | Clin Hematol Int | 2023 | 36811764 | PubTator, text mining | PubMed |
| Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia. | Cell Death Dis | 2023 | 36810326 | PubTator, text mining | PubMed |
| Review of genetic and pharmacogenetic differences in cytotoxic and targeted therapies for pancreatic cancer in African Americans. | J Natl Med Assoc | 2023 | 36801148 | PubTator, text mining | PubMed |
| Biochemistry-Not Oncogenes-May Demystify and Defeat Cancer. | Oncol Ther | 2023 | 36781712 | PubTator, text mining | PubMed |
| The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer. | Int J Mol Sci | 2023 | 36769170 | PubTator, text mining | PubMed |
| Regulatory Role of Ribonucleotide Reductase Subunit M2 in Hepatocyte Growth and Pathogenesis of Hepatitis C Virus. | Int J Mol Sci | 2023 | 36768940 | PubTator, text mining | PubMed |
| NMR Analysis Suggests Synergy between the RRM2 and the Carboxy-Terminal Segment of Human La Protein in the Recognition and Interaction with HCV IRES. | Int J Mol Sci | 2023 | 36768895 | PubTator, text mining | PubMed |
| Liaisons dangereuses: Intrinsic Disorder in Cellular Proteins Recruited to Viral Infection-Related Biocondensates. | Int J Mol Sci | 2023 | 36768473 | PubTator, text mining | PubMed |
| Development of Clinical Prediction Score for Chemotherapy Response in Advanced Non-Small Cell Lung Cancer Patients. | Healthcare (Basel) | 2023 | 36766868 | PubTator, text mining | PubMed |
| Data on the transcriptional response to MESH1 knockdown and mammalian stringent response. | Data Brief | 2023 | 36761407 | PubTator, text mining | PubMed |
| Novel roles of RNA-binding proteins in drug resistance of breast cancer: from molecular biology to targeting therapeutics. | Cell Death Discov | 2023 | 36759501 | PubTator, text mining | PubMed |
| HELLPAR/RRM2 axis related to HMMR as novel prognostic biomarker in gliomas. | BMC Cancer | 2023 | 36750807 | PubTator, text mining | PubMed |
| A hnRNPA2B1 agonist effectively inhibits HBV and SARS-CoV-2 omicron in vivo. | Protein Cell | 2023 | 36726760 | PubTator, text mining | PubMed |
| Ferroptosis as a Potential Cell Death Mechanism Against Cisplatin-Resistant Lung Cancer Cell Line. | Adv Pharm Bull | 2023 | 36721820 | PubTator, text mining | PubMed |
| Hemisynthetic alkaloids derived from trilobine are antimalarials with sustained activity in multidrug-resistant Plasmodium falciparum. | iScience | 2023 | 36718363 | PubTator, text mining | PubMed |
| Identification of ferroptosis related markers by integrated bioinformatics analysis and In vitro model experiments in rheumatoid arthritis. | BMC Med Genomics | 2023 | 36717858 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6240/papers?page=17